{
    "clinical_study": {
        "@rank": "114462", 
        "arm_group": [
            {
                "arm_group_label": "Diabetes mellitus type 2, Metformin", 
                "description": "The case group consists of patients with diagnosed diabetes mellitus type 2 treated with Metformin."
            }, 
            {
                "arm_group_label": "Diabetes mellitus type 2", 
                "description": "The control group consists of patients with diagnosed diabetes mellitus type 2 which do not have metformin treatment"
            }
        ], 
        "biospec_descr": {
            "textblock": "All blood samples investigated in this study will be destroyed one week after withdrawal.\n      All patient information obtained as a result of the study will be regarded as confidential\n      and made anonymous using a unique study ID number instead of name and surname of the\n      patient."
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "In this study we compare the vitamin B12 status by measuring serum vitamin B12 and\n      holotranscobalamin in type 2 diabetic patients with and without metformin treatment.\n      Afterwars we investigate which biomarker could be adequate to reflect B12 status in\n      metformin-treated patients.\n\n      With the help of a questionnaire we assess clinical, nutritional and demographic factors\n      which are associated with vitamin B12 deficiency."
        }, 
        "brief_title": "Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Vitamin B 12 Deficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of T2DM > 6 months\n\n          -  Metformin treatment for at least 6 months\n\n          -  Age > 18 years\n\n          -  Ability to give written informed consent\n\n          -  No metformin treatment in the last 6 months (control group)\n\n        Exclusion Criteria:\n\n          -  Concurrent intake of preparations containing VB12 (within the last 3 months prior to\n             study participation)\n\n          -  Lack of written and/or oral understanding in German, French, Italian or English\n             languages\n\n          -  Diagnosis of Transcobolamin transporter defect\n\n          -  Diagnosis of Chronic or acute liver diseaseliver insufficiency with CHILD-PUGH scores\n             B and C and acute hepatitis\n\n          -  Diagnosis of Renal disease (Creatinine-Clearance <60 ml/min)renal insufficiency\n             stadium III, IV and V (KDOQI) and acute renal diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with diabetes mellitus type 2 treated with and without Metformin."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02111967", 
            "org_study_id": "PCRG_Metformin_CMG"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Diabetes mellitus type 2, Metformin", 
                    "Diabetes mellitus type 2"
                ], 
                "intervention_name": "Questionnaire administration", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Diabetes mellitus type 2, Metformin", 
                    "Diabetes mellitus type 2"
                ], 
                "intervention_name": "Laboratory biomarker analysis", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin B 12", 
                "Hydroxocobalamin", 
                "Vitamins", 
                "Metformin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 9, 2014", 
        "location": {
            "contact": {
                "email": "philipp.walter@unibas.ch", 
                "last_name": "Philipp Walter, Dr.", 
                "phone": "062 311 48 19"
            }, 
            "contact_backup": {
                "email": "corina.metaxas@unibas.ch", 
                "last_name": "Corina Metaxas, Msc", 
                "phone": "061 267 15 19"
            }, 
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "zip": "4056"
                }, 
                "name": "Pharmaceutical Care Research Group"
            }, 
            "investigator": {
                "last_name": "Philipp N Walter, Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "2", 
        "official_title": "Adequacy of Serum Vitamin B12 Meausrement in Type 2 Diabetic Patients Treated With Metformin in Comparison to Holotranscobalamin Measurement", 
        "overall_contact": {
            "email": "philipp.walter@unibas.ch", 
            "last_name": "Philipp N Walter, Dr.", 
            "phone": "062 311 48 19"
        }, 
        "overall_contact_backup": {
            "email": "corina.metaxas@unibas.ch", 
            "last_name": "Corina Metaxas, MSc", 
            "phone": "061 267 15 19"
        }, 
        "overall_official": [
            {
                "affiliation": "Pharmaceutical Care Research Group", 
                "last_name": "Kurt E Hersberger, Prof.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Pharmaceutical Care Research Group", 
                "last_name": "Philipp N Walter, Dr.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Kantonsspital Olten", 
                "last_name": "Gottfried Rudofsky, Prof. Dr.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Laws and standards", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "VB12, HoloTc", 
            "measure": "Measurements of serum vitamin B12 and serum holotranscobalamin concentrations", 
            "safety_issue": "No", 
            "time_frame": "day 3"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02111967"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Basel", 
            "investigator_full_name": "Philipp Walter, PhD", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Clinical, nutritional and demographic factors which are associated with vitamin B12 deficiency  should be determined in patients with T2DM.", 
            "measure": "Questionnaire results", 
            "safety_issue": "No", 
            "time_frame": "day 8"
        }, 
        "source": "University Hospital, Basel, Switzerland", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Basel", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Solothurner Spit\u00e4ler AG", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University Hospital, Basel, Switzerland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}